dorzolamide


Also found in: Wikipedia.

dorzolamide

 [dor-zo´lah-mīd]
a carbonic acid anhydrase inhibitor, used in treatment of open-angle glaucoma and ocular hypertension; administered topically to the conjunctiva as the hydrochloride salt.

dorzolamide

/dor·zo·la·mide/ (dor-zo´lah-mīd) a carbonic acid anhydrase inhibitor, used as an antiglaucoma agent in the treatment of open-angle glaucoma and ocular hypertension; applied topically to the conjunctiva as the hydrochloride salt.

dorzolamide

A CARBONIC ANHYDRASE inhibitor drug used in the form of eyedrops to treat open angle GLAUCOMA. A brand name is Trusopt.

carbonic anhydrase inhibitors 

Drugs which inhibit the carbonic anhydrase enzyme in the ciliary epithelium of the ciliary body. This enzyme is essential for the formation of aqueous humour; its reduction results in a decrease in intraocular pressure. Those in use are sulfonamide derivatives. They are administered systemically (e.g. acetazolamide) or topically in the treatment of glaucoma. Examples: acetazolamide, brinzolamide, dichlorphenamide, dorzolamide.

dorzolamide

a topical carbonic anhydrase inhibitor used in the treatment of glaucoma.
References in periodicals archive ?
M2 PHARMA-February 1, 2018-Imprimis Pharmaceuticals Dispenses Preservative-free Dorzolamide and Dorzolamide/timolol in US
Georgarakis, Chitosan Nanoparticles Loaded with Dorzolamide and Pramipexole, Carbohydr.
A comparative analysis of the effects of the fixed combination of timolol and dorzolamide versus latanoprost plus timolol on ocular hemodynamics and visual function in patients with primary open-angle glaucoma.
Dorzolamide Dorzolamide Conjunctival 2% 5ml BC hyperaemia, (20mg/ml) Trusopt pain, diplopia, 2%, 5mL BC taste disorders, 2% Unit dose Preservative free depression.
Dorzolamide is a carbonic anhydrase inhibitor (CAI) that reduces the activity of carbonic anhydrase II secreted by non-pigmented ciliary epithelial cells, which keeps bicarbonate ions from being transported along with the sodium cation to the posterior chamber of the eye.
005% and as one drop, twice daily (8:00 AM and 8:00 PM) for dorzolamide hydrochloride 2%, brinzolamide 1%, and brimonidine tartrate 0.
One group was giventopical 2% dorzolamide, second was given oral acetazolamide and the third group received no medicines prior to capsulotomy.
Patient received after laser surgery only topical anti-inflammatory medication (steroidal and non-steroidal); for preventing IOP spikes, she was prescribed timolol and dorzolamide (Cosopt[R]) with good control of IOP in both eyes (IOP OD = 12 mmHg, IOP OS = 10 mmHg).
A 24-year-old pregnant patient (16 weeks) was referred to the glaucoma service due to an uncontrolled IOP in her left eye on maximum tolerable topical anti-glaucoma medications (timolol, dorzolamide, latanoprost, and brimonidine) by her local ophthalmologist.
2,4,6) Mechanism Drug Class Preparations of Action Reduction Adrenergic Brimonidine of Aqueous agonists Apraclonidine Inflow [beta]-blockers Non-selective Timolol Levobunolol Carteolol Selective [beta]-blockers Betaxolol Carbonic Systemic anhydrase Acetazolamide inhibitors Methazolamide Dichlorphenamide Topical Dorzolamide Brinzolamide Increase Cholinergics Pilocarpine in Aqueous Increase Carbachol Outflow trabecular outflow Prostaglandins Latanoprost (xalatan) and other lipid Travoprost (travatan) receptor agonists Increase Bimatoprost (lumigan) uveoscleral Unoprostone outflow Table 2: The Demographic Data of the Patients of POAG Selected for the Study Bimatoprost Timolol Maleate No.
Carbonic anhydrase inhibitors include brinzolamide (Azopt), which has no human eye data, and dorzolamide (Trusopt), which has growth restriction in one case treated with fixed combination of dorzolamide and timolol.
has received approval from the Food and Drug Administration of its ANDA for dorzolamide hydrochloride and timolol maleate ophthalmic solution, 2%/0.